{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:29:18Z","timestamp":1760646558336},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T00:00:00Z","timestamp":1464220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gaceta Sanitaria"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.gaceta.2016.04.020","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T06:50:11Z","timestamp":1478760611000},"page":"99-105","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S1","title":["Intervenciones de reducci\u00f3n de da\u00f1os en usuarios de drogas: situaci\u00f3n actual y recomendaciones"],"prefix":"10.1016","volume":"30","author":[{"given":"Marina","family":"Bosque-Prous","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Teresa","family":"Brugal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gaceta.2016.04.020_bib0255","series-title":"Harm reduction: evidence, impacts and challenges","author":"Rhodes","year":"2010"},{"key":"10.1016\/j.gaceta.2016.04.020_bib0260","series-title":"What is harm reduction? A position statement from the International Harm Reduction Association","year":"2010"},{"key":"10.1016\/j.gaceta.2016.04.020_bib0265","series-title":"WHO Expert Committee on Drug Dependence. Twentieth report","first-page":"1","year":"1974"},{"key":"10.1016\/j.gaceta.2016.04.020_bib0270","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0275","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000377626","article-title":"Lethality of opioid overdose in a community cohort of young heroin users","volume":"21","author":"Espelt","year":"2015","journal-title":"Eur Addict Res."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0280","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2105\/AJPH.91.5.774","article-title":"The impact of harm-reduction-based methadone treatment on mortality among heroin users","volume":"91","author":"Langendam","year":"2001","journal-title":"Am J Public Health."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0285","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(86)91570-9","article-title":"Preventing AIDS in drug addicts in Amsterdam","volume":"1","author":"Buning","year":"1986","journal-title":"Lancet."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0290","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.drugpo.2006.12.012","article-title":"\u00abHarm reduction - coming of age\u00bb: a local movement with global impact","volume":"18","author":"Stimson","year":"2007","journal-title":"Int J Drug Policy."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0295","series-title":"The global state of harm reduction 2008: mapping the response to drug-related HIV and hepatitis C epidemics","author":"Cook","year":"2008"},{"key":"10.1016\/j.gaceta.2016.04.020_bib0300","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0305","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","article-title":"A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride","volume":"193","author":"Dole","year":"1965","journal-title":"JAMA."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0310","series-title":"The global state of harm reduction 2014","author":"Stone","year":"2014"},{"key":"10.1016\/j.gaceta.2016.04.020_bib0315","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage","volume":"375","author":"Mathers","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0320","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2471\/BLT.12.111054","article-title":"Methadone maintenance treatment in Spain: the success of a harm reduction approach","volume":"91","author":"Torrens","year":"2013","journal-title":"Bull World Health Organ."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0325","first-page":"CD004145","article-title":"Substitution treatment of injecting opioid users for prevention of HIV infection","author":"Gowing","year":"2008","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0330","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0335","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1360-0443.2005.01089.x","article-title":"Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain","volume":"100","author":"Brugal","year":"2005","journal-title":"Addiction."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0340","first-page":"224","article-title":"The reduction of intravenous heroin use, non-opiate abuse and crime during methadone maintenance treatment: further findings","volume":"81","author":"Ball","year":"1988","journal-title":"NIDA Res Monogr."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0345","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","article-title":"The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis","volume":"93","author":"Marsch","year":"1998","journal-title":"Addiction."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0350","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","article-title":"Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed","volume":"376","author":"Degenhardt","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0355","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.drugpo.2005.02.004","article-title":"Effectiveness of sterile needle and syringe programmes","volume":"16","author":"Wodak","year":"2005","journal-title":"Int J Drug Policy."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0360","series-title":"Preventing HIV infection among injecting drug users in high-risk countries: an assessment of the evidence","author":"Tilson","year":"2007"},{"key":"10.1016\/j.gaceta.2016.04.020_bib0365","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.socscimed.2007.05.004","article-title":"More free syringes, fewer drug injectors in the case of Spain","volume":"65","author":"Bravo","year":"2007","journal-title":"Soc Sci Med."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0370","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00042560-200111010-00014","article-title":"Needle exchange programs and experience of violence in an inner city neighborhood","volume":"28","author":"Galea","year":"2001","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0375","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2105\/AJPH.90.12.1933","article-title":"Trends in crime and the introduction of a needle exchange program","volume":"90","author":"Marx","year":"2000","journal-title":"Am J Public Health."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0380","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","article-title":"Supervised injection services: what has been demonstrated? A systematic literature review","volume":"145","author":"Potier","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0385","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1360-0443.2008.02474.x","article-title":"Use of supervised injection facilities and injection risk behaviours among young drug injectors","volume":"104","author":"Bravo","year":"2009","journal-title":"Addiction."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0390","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","article-title":"Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study","volume":"377","author":"Marshall","year":"2011","journal-title":"Lancet."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0395","series-title":"European report on drug consumption rooms","author":"Hedrich","year":"2004"},{"key":"10.1016\/j.gaceta.2016.04.020_bib0400","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/bmj.332.7535.220","article-title":"Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study","volume":"332","author":"Kerr","year":"2006","journal-title":"BMJ."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0405","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.drugpo.2006.11.010","article-title":"Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre","volume":"18","author":"Salmon","year":"2007","journal-title":"Int J Drug Policy."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0410","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1503\/cmaj.1040774","article-title":"Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users","volume":"171","author":"Wood","year":"2004","journal-title":"CMAJ."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0415","doi-asserted-by":"crossref","first-page":"333","DOI":"10.20882\/adicciones.35","article-title":"Safe injection rooms and police crackdowns in areas with heavy drug dealing. Evaluation by counting discarded syringes collected from the public space","volume":"25","author":"Vecino","year":"2013","journal-title":"Adicciones."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0420","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1360-0443.2005.01259.x","article-title":"Take-home naloxone to reduce heroin death","volume":"100","author":"Baca","year":"2005","journal-title":"Addiction."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0425","series-title":"Naloxon - \u00dcberlebenshilfe im Drogennotfall.","article-title":"Implementation of systematic programs of overdose training at drug treatment and prevention centres in Catalonia, 2008-2013","author":"Espelt","year":"2015"},{"key":"10.1016\/j.gaceta.2016.04.020_bib0430","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1300\/J069v25n03_11","article-title":"Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths","volume":"25","author":"Maxwell","year":"2006","journal-title":"J Addict Dis."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0435","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1360-0443.2011.03759.x","article-title":"Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates","volume":"107","author":"Barrio","year":"2012","journal-title":"Addiction."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0440","first-page":"169","article-title":"The evolution of AIDS mortality and survival in Barcelona (1981-1997)","volume":"113","author":"Garc\u00eda de Olalla","year":"1999","journal-title":"Med Cl\u00edn."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0445","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/1471-2458-13-338","article-title":"Time series analysis comparing mandatory and voluntary notification of newly diagnosed HIV infections in a city with a concentrated epidemic","volume":"13","author":"Reyes-Urue\u00f1a","year":"2013","journal-title":"BMC Public Health."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0450","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jech.2005.037333","article-title":"Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes","volume":"60","author":"de la Fuente","year":"2006","journal-title":"J Epidemiol Community Health."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0455","series-title":"Delegaci\u00f3n del Gobierno para el Plan Nacional sobre Drogas. Plan Nacional sobre Drogas. Memoria 2012","year":"2014"},{"key":"10.1016\/j.gaceta.2016.04.020_bib0460","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/oxfordjournals.aje.a117472","article-title":"Use of capture-recapture to estimate the prevalence of opiate addiction in Barcelona, Spain, 1989","volume":"141","author":"Domingo-Salvany","year":"1995","journal-title":"Am J Epidemiol."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0465","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0213-9111(00)71429-4","article-title":"Coping with the toll of heroin: 10 years of the Barcelona Action Plan on Drugs, Spain","volume":"14","author":"Manzanera","year":"2000","journal-title":"Gac Sanit."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0470","doi-asserted-by":"crossref","first-page":"S410","DOI":"10.1086\/377562","article-title":"Lessons from the history of the human immunodeficiency virus\/acquired immunodeficiency syndrome epidemic among Spanish drug injectors","volume":"37","author":"de la Fuente","year":"2003","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0475","series-title":"European Monitoring Centre for Drugs and Drug Addiction. Perspectives on drugs: drug consumption rooms: an overview of provision and evidence","year":"2015"},{"key":"10.1016\/j.gaceta.2016.04.020_bib0480","series-title":"No en la puerta de mi casa: implantaci\u00f3n no conflictiva de dispositivos de drogodependencias","author":"Sep\u00falveda","year":"2008"},{"key":"10.1016\/j.gaceta.2016.04.020_bib0485","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(10)61053-7","article-title":"The health of prisoners","volume":"377","author":"Fazel","year":"2011","journal-title":"Lancet."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0490","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(10)60830-6","article-title":"People who use drugs, HIV, and human rights","volume":"376","author":"J\u00fcrgens","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0495","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1086\/651482","article-title":"Prevention of HIV infection among injection drug users in resource-limited settings","volume":"50","author":"Vlahov","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.gaceta.2016.04.020_bib0500","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/add.12899","article-title":"Global statistics on addictive behaviours: 2014 status report","volume":"110","author":"Gowing","year":"2015","journal-title":"Addiction."}],"container-title":["Gaceta Sanitaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213911116300838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213911116300838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T21:27:53Z","timestamp":1536269273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213911116300838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":50,"alternative-id":["S0213911116300838"],"URL":"https:\/\/doi.org\/10.1016\/j.gaceta.2016.04.020","relation":{},"ISSN":["0213-9111"],"issn-type":[{"value":"0213-9111","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intervenciones de reducci\u00f3n de da\u00f1os en usuarios de drogas: situaci\u00f3n actual y recomendaciones","name":"articletitle","label":"Article Title"},{"value":"Gaceta Sanitaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gaceta.2016.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 SESPAS. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}